Learn more

MORPHOCHEM AG AG FUER KOMBINAT

Overview
  • Total Patents
    13
About

MORPHOCHEM AG AG FUER KOMBINAT has a total of 13 patent applications. Its first patent ever was published in 2001. It filed its patents most often in Germany. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are FUJIAN HAIXI PHARMACEUTICALS CO LTD, VIIV HEALTHCARE UK NO 5 LTD and JUBILANT BIOSYS LTD.

Patent filings in countries

World map showing MORPHOCHEM AG AG FUER KOMBINATs patent filings in countries
# Country Total Patents
#1 Germany 13

Patent filings per year

Chart showing MORPHOCHEM AG AG FUER KOMBINATs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Doemling Alexander 4
#2 Henkel Bernd 3
#3 Weber Lutz 3
#4 Hubschwerlen Christian 2
#5 Zumbrunn Cornelia 2
#6 Surivet Jean-Philippe 2
#7 Mueller Thomas J J 2
#8 Thormann Michael 2
#9 Beck Barbara 2
#10 Illgen Katrin 1

Latest patents

Publication Filing date Title
DE10328400A1 One-pot synthesis of carbocyclic or heterocyclic compounds, especially pyrimidine useful as components of natural products or drugs, from acid halide, alkyne and active hydrogen compound
DE10320453A1 New Actinonin Bioisosteres
DE10316081A1 New compounds with antibacterial activity
DE10305531A1 New tubulysin compound conjugates with polymers or biomolecules, having reduced toxicity compared with parent tubulysin, especially useful for treating tumor diseases
DE10300049A1 New compounds that inhibit factor VIIa
DE10256976A1 Use of specific hydroxamic acids for inhibition of methionine aminopeptidase, useful for treatment of bacterial or fungal infections, or cancers and other diseases associated with angiogenesis
DE10252719A1 New tubulysin analogs, useful for treating tumor or cancer diseases, immunologically induced or autoimmune diseases, inflammatory diseases or rheumatoid arthritis or for surface modification of implants
DE10247233A1 New 4-substituted quinoline derivatives, useful for treating bacterial infections, optionally including additional ring nitrogens
DE10230872A1 Process for the preparation of substituted thiazol-2-ylmethyl esters
DE10230875A1 New tubulysin compound conjugates with polymers or biomolecules, having reduced toxicity compared with parent tubulysin, especially useful for treating tumor diseases
DE10230874A1 New tubulysin analogs, useful for treating tumor or cancer diseases, immunologically induced or autoimmune diseases, inflammatory diseases or rheumatoid arthritis or for surface modification of implants
DE10223908A1 Process for the preparation of substituted pyridines
DE10162134A1 Resin-bound isonitriles